Although the proteolytic enzyme caspase-3 (CASP3) could initiates apoptosis by cleaving and inactivating PARP1, it also could stimulate survived breast cancer cell growth by promoting PGE2 release [57]. The gene discussed is PARP1; the disease is breast carcinoma.